These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5833101)

  • 1. [On disturbances in space perception caused by Parkinson's syndrome].
    Metzel E
    Dtsch Med Wochenschr; 1965 Oct; 90(44):1955-7. PubMed ID: 5833101
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the treatment of Parkinson's syndrome with monoamine oxidase inhibitors alone and in combination with L-dopa].
    Gerstenbrand F; Prosenz P
    Praxis; 1965 Nov; 54(46):1373-7. PubMed ID: 5899418
    [No Abstract]   [Full Text] [Related]  

  • 3. [The trial of intravenous L-DOPA in patients with Parkinson's disease].
    Nardini M; Fieschi C; Agnoli A; Arcioli I; Zanette E
    Riv Neurol; 1970; 40(2):75-85. PubMed ID: 5429003
    [No Abstract]   [Full Text] [Related]  

  • 4. [Parkinson's disease: current therapeutic aspects].
    Casati C
    Clin Ter; 1971 Jan; 56(1):71-9. PubMed ID: 4944741
    [No Abstract]   [Full Text] [Related]  

  • 5. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R
    Med Klin; 1969 Aug; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of Parkinson's syndrome with L-dopa].
    Kaeser HE; Ferel D; Wurmser P
    Schweiz Med Wochenschr; 1970 May; 100(19):805-13. PubMed ID: 4924276
    [No Abstract]   [Full Text] [Related]  

  • 7. [A contribution to the biochemical treatment of the akinetic type of the Parkinson's syndrome].
    Völler GW
    Med Welt; 1968 Feb; 5():338-41. PubMed ID: 5668416
    [No Abstract]   [Full Text] [Related]  

  • 8. Parkinson's disease; modern treatment.
    Tolosa E
    Minn Med; 1973 Jun; 56(6):497-502. PubMed ID: 4575903
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of parkinsonism using L-dopa. I].
    Glass J
    Z Arztl Fortbild (Jena); 1972 Dec; 66(23):1195-9. PubMed ID: 4652156
    [No Abstract]   [Full Text] [Related]  

  • 10. An open study with reversible MAO-A inhibitors in complicated Parkinson's disease.
    Ruggieri S; Fabbrini G; Bramante L; DePandis F; Stocchi F; Barbanti P; Vacca L; Manfredi M
    Adv Neurol; 1996; 69():595-8. PubMed ID: 8615185
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyposmia in Parkinson's disease.
    Alvarez MV; Grogan PM
    Psychiatry Clin Neurosci; 2012 Jun; 66(4):370. PubMed ID: 22624744
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
    Henchcliffe C; Schumacher HC; Burgut FT
    Expert Rev Neurother; 2005 Nov; 5(6):811-21. PubMed ID: 16274338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of parkinsonian akinesia].
    Travenets IA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(5):703-6. PubMed ID: 5998829
    [No Abstract]   [Full Text] [Related]  

  • 14. MAO-B inhibitors in Parkinson's disease.
    Olanow CW
    Adv Neurol; 1993; 60():666-71. PubMed ID: 8420207
    [No Abstract]   [Full Text] [Related]  

  • 15. MAO-B inhibitors for the treatment of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S38-44. PubMed ID: 12211138
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination treatment with selective monoamine oxidase inhibitors and dopaminergic agonists in Parkinson's disease: biochemical and clinical observations.
    Riederer P; Jellinger K; Danielczyk W; Seemann D; Ulm G; Reynolds GP; Birkmayer W; Koppel H
    Adv Neurol; 1983; 37():159-76. PubMed ID: 6407285
    [No Abstract]   [Full Text] [Related]  

  • 17. Using monoamine oxidase type B inhibitors in Parkinson's disease.
    Ben-Shlomo Y; Bhatia K
    BMJ; 2004 Sep; 329(7466):581-2. PubMed ID: 15361418
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent progress in treatment of Parkinson's disease].
    Narabayashi H
    Nihon Rinsho; 1990 Dec; 48(12):2943-50. PubMed ID: 2086859
    [No Abstract]   [Full Text] [Related]  

  • 19. [10 years of L-DOPA therapy of Parkinson's syndrome].
    Birkmayer W
    Wien Klin Wochenschr; 1971 Apr; 83(13):221-7. PubMed ID: 4254333
    [No Abstract]   [Full Text] [Related]  

  • 20. [Parkinson's syndrome. 10. Effects of psychopharmacological agents on central monoamine neurons].
    Roos BE
    Lakartidningen; 1970 Oct; 67(42):4840-1. PubMed ID: 4320249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.